K. Penne

Gefitinib (IressaTM, ZD1839) and Tyrosine Kinase Inhibitors: The Wave of the Future in Cancer Therapy

K. Penne, C. Bohlin, S. Schneider, 2005, Cancer nursing.

tolerabil-Phase II study of Cloretazine for the treatment of adults with recurrent glioblastoma multiforme 1 Neuro-oNcology

D. Bigner, H. Friedman, D. Reardon, 2006 .

Using evidence in central catheter care.

K. Penne, 2002, Seminars in oncology nursing.

Phase II study of Cloretazine for the treatment of adults with recurrent glioblastoma multiforme.

A. Friedman, D. Bigner, H. Friedman, 2007, Neuro-oncology.

Feeding Jejunostomy Tube Placement in Patients Undergoing Pancreaticoduodenectomy: An Ongoing Dilemma

D. Tyler, B. Clary, S. Stinnett, 2014, Journal of Gastrointestinal Surgery.

Progress Report of a Phase I Study of the Intracerebral Microinfusion of a Recombinant Chimeric Protein Composed of Transforming Growth Factor (TGF)-α and a Mutated form of the Pseudomonas Exotoxin Termed PE-38 (TP-38) for the Treatment of Malignant Brain Tumors

M. Berger, R. McLendon, A. Friedman, 2003, Journal of Neuro-Oncology.

Phase II trial of gefitinib in recurrent glioblastoma.

Allan H Friedman, R. McLendon, A. Friedman, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A standardized care plan is associated with shorter hospital length of stay in patients undergoing pancreaticoduodenectomy.

D. Tyler, B. Clary, S. Stinnett, 2015, The Journal of surgical research.

The role of clinical care pathways: an experience with distal pancreatectomy.

Sandra S Stinnett, D. Tyler, B. Clary, 2014, The Journal of surgical research.